These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 34800363)

  • 1. Bi-allelic variants in OGDHL cause a neurodevelopmental spectrum disease featuring epilepsy, hearing loss, visual impairment, and ataxia.
    Yap ZY; Efthymiou S; Seiffert S; Vargas Parra K; Lee S; Nasca A; Maroofian R; Schrauwen I; Pendziwiat M; Jung S; Bhoj E; Striano P; Mankad K; Vona B; Cuddapah S; Wagner A; Alvi JR; Davoudi-Dehaghani E; Fallah MS; Gannavarapu S; Lamperti C; Legati A; Murtaza BN; Nadeem MS; Rehman MU; Saeidi K; Salpietro V; von Spiczak S; Sandoval A; Zeinali S; Zeviani M; Reich A; ; ; Jang C; Helbig I; Barakat TS; Ghezzi D; Leal SM; Weber Y; Houlden H; Yoon WH
    Am J Hum Genet; 2021 Dec; 108(12):2368-2384. PubMed ID: 34800363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biallelic pathogenic variant in the OGDH gene results in a neurological disorder with features of a mitochondrial disease.
    Yap ZY; Strucinska K; Matsuzaki S; Lee S; Si Y; Humphries K; Tarnopolsky MA; Yoon WH
    J Inherit Metab Dis; 2021 Mar; 44(2):388-400. PubMed ID: 32383294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biallelic variants in OGDH encoding oxoglutarate dehydrogenase lead to a neurodevelopmental disorder characterized by global developmental delay, movement disorder, and metabolic abnormalities.
    Whittle EF; Chilian M; Karimiani EG; Progri H; Buhas D; Kose M; Ganetzky RD; Toosi MB; Torbati PN; Badv RS; Shelihan I; Yang H; Elloumi HZ; Lee S; Jamshidi Y; Pittman AM; Houlden H; Ignatius E; Rahman S; Maroofian R; Yoon WH; Carroll CJ
    Genet Med; 2023 Feb; 25(2):100332. PubMed ID: 36520152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity.
    Lin SJ; Vona B; Lau T; Huang K; Zaki MS; Aldeen HS; Karimiani EG; Rocca C; Noureldeen MM; Saad AK; Petree C; Bartolomaeus T; Abou Jamra R; Zifarelli G; Gotkhindikar A; Wentzensen IM; Liao M; Cork EE; Varshney P; Hashemi N; Mohammadi MH; Rad A; Neira J; Toosi MB; Knopp C; Kurth I; Challman TD; Smith R; Abdalla A; Haaf T; Suri M; Joshi M; Chung WK; Moreno-De-Luca A; Houlden H; Maroofian R; Varshney GK
    Genome Med; 2023 Nov; 15(1):102. PubMed ID: 38031187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy.
    Usmani MA; Ahmed ZM; Magini P; Pienkowski VM; Rasmussen KJ; Hernan R; Rasheed F; Hussain M; Shahzad M; Lanpher BC; Niu Z; Lim FY; Pippucci T; Ploski R; Kraus V; Matuszewska K; Palombo F; Kianmahd J; ; Martinez-Agosto JA; Lee H; Colao E; Motazacker MM; Brigatti KW; Puffenberger EG; Riazuddin SA; Gonzaga-Jauregui C; Chung WK; Wagner M; Schultz MJ; Seri M; Kievit AJA; Perrotti N; Wassink-Ruiter JSK; van Bokhoven H; Riazuddin S; Riazuddin S
    Am J Hum Genet; 2021 Jul; 108(7):1330-1341. PubMed ID: 34102099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biallelic variants in
    Maroofian R; Sedmík J; Mazaheri N; Scala M; Zaki MS; Keegan LP; Azizimalamiri R; Issa M; Shariati G; Sedaghat A; Beetz C; Bauer P; Galehdari H; O'Connell MA; Houlden H
    J Med Genet; 2021 Jul; 58(7):495-504. PubMed ID: 32719099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoallelic and bi-allelic variants in NCDN cause neurodevelopmental delay, intellectual disability, and epilepsy.
    Fatima A; Hoeber J; Schuster J; Koshimizu E; Maya-Gonzalez C; Keren B; Mignot C; Akram T; Ali Z; Miyatake S; Tanigawa J; Koike T; Kato M; Murakami Y; Abdullah U; Ali MA; Fadoul R; Laan L; Castillejo-López C; Liik M; Jin Z; Birnir B; Matsumoto N; Baig SM; Klar J; Dahl N
    Am J Hum Genet; 2021 Apr; 108(4):739-748. PubMed ID: 33711248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome.
    Salpietro V; Maroofian R; Zaki MS; Wangen J; Ciolfi A; Barresi S; Efthymiou S; Lamaze A; Aughey GN; Al Mutairi F; Rad A; Rocca C; Calì E; Accogli A; Zara F; Striano P; Mojarrad M; Tariq H; Giacopuzzi E; Taylor JC; Oprea G; Skrahina V; Rehman KU; Abd Elmaksoud M; Bassiony M; El Said HG; Abdel-Hamid MS; Al Shalan M; Seo G; Kim S; Lee H; Khang R; Issa MY; Elbendary HM; Rafat K; Marinakis NM; Traeger-Synodinos J; Ververi A; Sourmpi M; Eslahi A; Khadivi Zand F; Beiraghi Toosi M; Babaei M; Jackson A; ; Bertoli-Avella A; Pagnamenta AT; Niceta M; Battini R; Corsello A; Leoni C; Chiarelli F; Dallapiccola B; Faqeih EA; Tallur KK; Alfadhel M; Alobeid E; Maddirevula S; Mankad K; Banka S; Ghayoor-Karimiani E; Tartaglia M; Chung WK; Green R; Alkuraya FS; Jepson JEC; Houlden H
    Am J Hum Genet; 2024 Jan; 111(1):200-210. PubMed ID: 38118446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo FZR1 loss-of-function variants cause developmental and epileptic encephalopathies.
    Manivannan SN; Roovers J; Smal N; Myers CT; Turkdogan D; Roelens F; Kanca O; Chung HL; Scholz T; Hermann K; Bierhals T; Caglayan HS; Stamberger H; ; Mefford H; de Jonghe P; Yamamoto S; Weckhuysen S; Bellen HJ
    Brain; 2022 Jun; 145(5):1684-1697. PubMed ID: 34788397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bi-allelic ACBD6 variants lead to a neurodevelopmental syndrome with progressive and complex movement disorders.
    Kaiyrzhanov R; Rad A; Lin SJ; Bertoli-Avella A; Kallemeijn WW; Godwin A; Zaki MS; Huang K; Lau T; Petree C; Efthymiou S; Karimiani EG; Hempel M; Normand EA; Rudnik-Schöneborn S; Schatz UA; Baggelaar MP; Ilyas M; Sultan T; Alvi JR; Ganieva M; Fowler B; Aanicai R; Tayfun GA; Al Saman A; Alswaid A; Amiri N; Asilova N; Shotelersuk V; Yeetong P; Azam M; Babaei M; Monajemi GB; Mohammadi P; Samie S; Banu SH; Pinto Basto J; Kortüm F; Bauer M; Bauer P; Beetz C; Garshasbi M; Issa AH; Eyaid W; Ahmed H; Hashemi N; Hassanpour K; Herman I; Ibrohimov S; Abdul-Majeed BA; Imdad M; Isrofilov M; Kaiyal Q; Khan S; Kirmse B; Koster J; Lourenço CM; Mitani T; Moldovan O; Murphy D; Najafi M; Pehlivan D; Rocha ME; Salpietro V; Schmidts M; Shalata A; Mahroum M; Talbeya JK; Taylor RW; Vazquez D; Vetro A; Waterham HR; Zaman M; Schrader TA; Chung WK; Guerrini R; Lupski JR; Gleeson J; Suri M; Jamshidi Y; Bhatia KP; Vona B; Schrader M; Severino M; Guille M; Tate EW; Varshney GK; Houlden H; Maroofian R
    Brain; 2024 Apr; 147(4):1436-1456. PubMed ID: 37951597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare EIF4A2 variants are associated with a neurodevelopmental disorder characterized by intellectual disability, hypotonia, and epilepsy.
    Paul MS; Duncan AR; Genetti CA; Pan H; Jackson A; Grant PE; Shi J; Pinelli M; Brunetti-Pierri N; Garza-Flores A; Shahani D; Saneto RP; Zampino G; Leoni C; Agolini E; Novelli A; Blümlein U; Haack TB; Heinritz W; Matzker E; Alhaddad B; Abou Jamra R; Bartolomaeus T; AlHamdan S; Carapito R; Isidor B; Bahram S; Ritter A; Izumi K; Shakked BP; Barel O; Ben Zeev B; Begtrup A; Carere DA; Mullegama SV; Palculict TB; Calame DG; Schwan K; Aycinena ARP; Traberg R; ; Douzgou S; Pirt H; Ismayilova N; Banka S; Chao HT; Agrawal PB
    Am J Hum Genet; 2023 Jan; 110(1):120-145. PubMed ID: 36528028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bi-allelic loss-of-function variants in PPFIBP1 cause a neurodevelopmental disorder with microcephaly, epilepsy, and periventricular calcifications.
    Rosenhahn E; O'Brien TJ; Zaki MS; Sorge I; Wieczorek D; Rostasy K; Vitobello A; Nambot S; Alkuraya FS; Hashem MO; Alhashem A; Tabarki B; Alamri AS; Al Safar AH; Bubshait DK; Alahmady NF; Gleeson JG; Abdel-Hamid MS; Lesko N; Ygberg S; Correia SP; Wredenberg A; Alavi S; Seyedhassani SM; Ebrahimi Nasab M; Hussien H; Omar TEI; Harzallah I; Touraine R; Tajsharghi H; Morsy H; Houlden H; Shahrooei M; Ghavideldarestani M; Abdel-Salam GMH; Torella A; Zanobio M; Terrone G; Brunetti-Pierri N; Omrani A; Hentschel J; Lemke JR; Sticht H; Abou Jamra R; Brown AEX; Maroofian R; Platzer K
    Am J Hum Genet; 2022 Aug; 109(8):1421-1435. PubMed ID: 35830857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy.
    Marafi D; Mitani T; Isikay S; Hertecant J; Almannai M; Manickam K; Abou Jamra R; El-Hattab AW; Rajah J; Fatih JM; Du H; Karaca E; Bayram Y; Punetha J; Rosenfeld JA; Jhangiani SN; Boerwinkle E; Akdemir ZC; Erdin S; Hunter JV; Gibbs RA; Pehlivan D; Posey JE; Lupski JR
    Ann Clin Transl Neurol; 2020 May; 7(5):610-627. PubMed ID: 32286009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interpretation of ATAD3A variants in neuro-mitochondrial phenotypes.
    Yap ZY; Park YH; Wortmann SB; Gunning AC; Ezer S; Lee S; Duraine L; Wilichowski E; Wilson K; Mayr JA; Wagner M; Li H; Kini U; Black ED; Monaghan KG; Lupski JR; Ellard S; Westphal DS; Harel T; Yoon WH
    Genome Med; 2021 Apr; 13(1):55. PubMed ID: 33845882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic loss-of-function variants in the splicing regulator NSRP1 cause a severe neurodevelopmental disorder with spastic cerebral palsy and epilepsy.
    Calame DG; Bakhtiari S; Logan R; Coban-Akdemir Z; Du H; Mitani T; Fatih JM; Hunter JV; Herman I; Pehlivan D; Jhangiani SN; Person R; Schnur RE; Jin SC; Bilguvar K; Posey JE; Koh S; Firouzabadi SG; Alehabib E; Tafakhori A; Esmkhani S; Gibbs RA; Noureldeen MM; Zaki MS; Marafi D; Darvish H; Kruer MC; Lupski JR
    Genet Med; 2021 Dec; 23(12):2455-2460. PubMed ID: 34385670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiencies in vesicular transport mediated by TRAPPC4 are associated with severe syndromic intellectual disability.
    Van Bergen NJ; Guo Y; Al-Deri N; Lipatova Z; Stanga D; Zhao S; Murtazina R; Gyurkovska V; Pehlivan D; Mitani T; Gezdirici A; Antony J; Collins F; Willis MJH; Coban Akdemir ZH; Liu P; Punetha J; Hunter JV; Jhangiani SN; Fatih JM; Rosenfeld JA; Posey JE; Gibbs RA; Karaca E; Massey S; Ranasinghe TG; Sleiman P; Troedson C; Lupski JR; Sacher M; Segev N; Hakonarson H; Christodoulou J
    Brain; 2020 Jan; 143(1):112-130. PubMed ID: 31794024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bi-allelic mutations in
    Milev MP; Graziano C; Karall D; Kuper WFE; Al-Deri N; Cordelli DM; Haack TB; Danhauser K; Iuso A; Palombo F; Pippucci T; Prokisch H; Saint-Dic D; Seri M; Stanga D; Cenacchi G; van Gassen KLI; Zschocke J; Fauth C; Mayr JA; Sacher M; van Hasselt PM
    J Med Genet; 2018 Nov; 55(11):753-764. PubMed ID: 30120216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eight further individuals with intellectual disability and epilepsy carrying bi-allelic CNTNAP2 aberrations allow delineation of the mutational and phenotypic spectrum.
    Smogavec M; Cleall A; Hoyer J; Lederer D; Nassogne MC; Palmer EE; Deprez M; Benoit V; Maystadt I; Noakes C; Leal A; Shaw M; Gecz J; Raymond L; Reis A; Shears D; Brockmann K; Zweier C
    J Med Genet; 2016 Dec; 53(12):820-827. PubMed ID: 27439707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAPPC6B biallelic variants cause a neurodevelopmental disorder with TRAPP II and trafficking disruptions.
    Almousa H; Lewis SA; Bakhtiari S; Nordlie SH; Pagnozzi A; Magee H; Efthymiou S; Heim JA; Cornejo P; Zaki MS; Anwar N; Maqbool S; Rahman F; Neilson DE; Vemuri A; Jin SC; Yang XR; Heidari A; van Gassen K; Trimouille A; Thauvin-Robinet C; Liu J; Bruel AL; Tomoum H; Shata MO; Hashem MO; Toosi MB; Karimiani EG; Yeşil G; Lingappa L; Baruah D; Ebrahimzadeh F; Van-Gils J; Faivre L; Zamani M; Galehdari H; Sadeghian S; Shariati G; Mohammad R; van der Smagt J; Qari A; Vincent JB; Innes AM; Dursun A; Özgül RK; Akar HT; Bilguvar K; Mignot C; Keren B; Raveli C; Burglen L; Afenjar A; Kaat LD; van Slegtenhorst M; Alkuraya F; Houlden H; Padilla-Lopez S; Maroofian R; Sacher M; Kruer MC
    Brain; 2024 Jan; 147(1):311-324. PubMed ID: 37713627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects.
    Manole A; Efthymiou S; O'Connor E; Mendes MI; Jennings M; Maroofian R; Davagnanam I; Mankad K; Lopez MR; Salpietro V; Harripaul R; Badalato L; Walia J; Francklyn CS; Athanasiou-Fragkouli A; Sullivan R; Desai S; Baranano K; Zafar F; Rana N; Ilyas M; Horga A; Kara M; Mattioli F; Goldenberg A; Griffin H; Piton A; Henderson LB; Kara B; Aslanger AD; Raaphorst J; Pfundt R; Portier R; Shinawi M; Kirby A; Christensen KM; Wang L; Rosti RO; Paracha SA; Sarwar MT; Jenkins D; ; Ahmed J; Santoni FA; Ranza E; Iwaszkiewicz J; Cytrynbaum C; Weksberg R; Wentzensen IM; Guillen Sacoto MJ; Si Y; Telegrafi A; Andrews MV; Baldridge D; Gabriel H; Mohr J; Oehl-Jaschkowitz B; Debard S; Senger B; Fischer F; van Ravenwaaij C; Fock AJM; Stevens SJC; Bähler J; Nasar A; Mantovani JF; Manzur A; Sarkozy A; Smith DEC; Salomons GS; Ahmed ZM; Riazuddin S; Riazuddin S; Usmani MA; Seibt A; Ansar M; Antonarakis SE; Vincent JB; Ayub M; Grimmel M; Jelsig AM; Hjortshøj TD; Karstensen HG; Hummel M; Haack TB; Jamshidi Y; Distelmaier F; Horvath R; Gleeson JG; Becker H; Mandel JL; Koolen DA; Houlden H
    Am J Hum Genet; 2020 Aug; 107(2):311-324. PubMed ID: 32738225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.